In the present study we assessed platelet APP, sAPPβ and serotonin in three different mouse models and human patients with AD; additionally, we evaluated platelet EGF levels in our human cohort, in order to evaluate whether these components are altered in AD and whether platelets are useful as peripheral biomarkers in AD. The gene discussed is APP; the disease is Alzheimer disease.